Time-Series Analysis of Meningococcal Disease in Catalonia

Annals of Epidemiology

Volumn 17, Issue 9, 2007, Pages 654-662

  Domínguez, Angela ^a   Muñoz, Pilar ^a   Cardeñosa, Neus ^a   Martínez, Ana ^a   Caylà, Joan ^a  

^a Publich Health Agency of Catalonia   (Spain)

Author keywords

Meningococcal disease; Serogroup B, Serogroup C; Time series analysis

Indexed keywords

MENINGOCOCCUS VACCINE;

ADULT; ARTICLE; CALCULATION; CORRELATION ANALYSIS; DISEASE COURSE; EPIDEMIC; FEMALE; HEALTH PROGRAM; HUMAN; INCIDENCE; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; POISSON REGRESSION MODEL; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROTYPE; SPAIN; TIME SERIES ANALYSIS; VACCINATION;

HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA, HUMAN; MENINGITIS, MENINGOCOCCAL; POISSON DISTRIBUTION; SPAIN; TIME FACTORS;

EID: 34548047246     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2007.03.006     Document Type: Article

References (33)

1. de Mateo Ontañon S. Meningococcal disease in Spain, 1990-1997. Changes in the epidemiological pattern. (in Spanish). Rev Esp Salud Publica 74 (2000) 387-396
2. Carmona G., Cardeñosa N., Oviedo M., Orcau A., Pañella H., Alsedà M., et al. Enfermedad meningocócica en Cataluña (1990-1997). Med Clin (Barc) 123 (2004) 486-489
3. Salleras L., Dominguez A., and Cardenosa N. Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain. Vaccine 21 (2003) 725-728
4. Salleras L., Dominguez A., Prats G., Parron I., and Muñoz P. Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people. J Epidemiol Community Health 55 (2001) 283-287
5. Cardeñosa N., Carmona G., Ciruela P., Martínez A., Torner N., and Domínguez A. Sensitivity and positive predictive value of the compulsory disease reporting system to meningococcal disease. 23rd Annual Meeting of the European Society for Pediatric Infectious Diseases-ESPID. Valencia (2005) 31
6. Cartwright K.A., Jones D.M., Smith A.J., Stuart J.M., Kaczmarski E.B., and Palmer S.R. Influenza A and meningococcal disease. Lancet 338 (1991) 554-557
7. Young L.S., LaForce F.M., Head J.J., Feeley J.C., and Bennett J.V. A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med 287 (1972) 5-9
8. Hubert B., Watier L., Garnerin P., and Richardson S. Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis 166 (1992) 542-545
9. Travaglini M., Gubler J., Buhlmann U., and Goetschel P. Varicella zoster virus infection complicated by Neisseria meningitidis bacteraemia in two children. Eur J Pediatr 160 (2001) 399-403
10. Maitland K. Temporal association of chickenpox and meningococcal disease in children: a report of three cases. Acta Paediatr 89 (2000) 744-745
11. Böhning D., Dietz E., and Schlattmann P. The zero-inflated Poisson model and the decayed, missing and filled teeth index in dental epidemiology. J R Statist Soc A 162 (1999) 195-209
12. Lambert D. Zero-inflated Poisson regression, with application to defects in manufacturing. Technometrics 34 (1992) 1-14
13. Squires S.G., Deeks S.L., and Tsang R.S. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001. Can Commun Dis Rep 30 (2004) 17-28
14. Fitzerald M., Colter S., Cafferkey M., and Murphy K. Meningococcal disease in Ireland, 2003-2004. EPI - insight (February 2005)
15. Perrochau A. Les infections invasives a meningocoque en France en 2003. Bull Epidemiol Hebdomadaire 46 (2004) 217-220
16. Sánchez J.A., Cano L., and Rios M. The seasonality and the recent changes of meningococcal disease in Spain (in Spanish). Gac Sanit 15 (2001) 336-340
17. Muñoz C., Palomeque A., Roca J., Gené A., Palacin E., and Latorre C. Aumento de la rentabilidad diagnóstica en la enfermedad meningocócica mediante la técnica de reacción en cadena de la polimerasa. Med Clin (Barc) 129 (2003) 721-724
18. Mothershed E.A., Sacchi C.T., Whitney A.M., Barnett G.A., Ajello G.W., Schmink S., et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol. 42 (2004) 320-328
19. Mooney J.D., Christie P., Robertson C., and Clarke S.C. The impact of meningococcal serogroup C conjugate vaccine in Scotland. Clin Infect Dis 39 (2004) 349-356
20. Moreno-Civantos A., Diaz-Jimenez J., and Dominguez-Berjon M.F. Shared surveillance: meningococcal disease vs influenza. Gac Sanit 14 (2000) 422-428
21. Moore P.S., Hierholzer J., DeWitt W., Gouan K., Djore D., Lippeveld T., et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 264 (1990) 1271-1275
22. Anderson M.S., Glodé M.P., and Al S. Meningococcal disease. In: Feigin R.D., Cherry J.D., Demmler G.J., and Kaplan S.L. (Eds). Textbook of Pediatric Infectious Diseases (2004), Elsevier, Philadelphia 1265-1280
23. Read R.C., Goodwin L., Parsons M.A., Silcocks P., Kaczmarski E.B., Parker A., et al. Coinfection with influenza B virus does not affect association of Neisseria meningitidis with human nasopharyngeal mucosa in organ culture. Infect Immun 67 (1999) 3082-3086
24. Scholten R.J., Bijlmer H.A., Tobi H., Dankert J., and Bouter L.M. Upper respiratory tract infection, heterologous immunisation and meningococcal disease. J Med Microbiol. 48 (1999) 943-946
25. Jensen E.S., Lundbye-Christensen S., Samuelsson S., Sorensen H.T., and Schonheyder H.C. A 20-year ecological study of the temporal association between influenza and meningococcal disease. Eur J Epidemiol 19 (2004) 181-187
26. Kaninda A.V., Belanger F., Lewis R., Batchassi E., Aplogan A., Yakoua Y., et al. Effectiveness of incidence thresholds for detection and control of meningococcal meningitis epidemics in northern Togo. Int J Epidemiol 29 (2000) 933-940
27. Nakhla I., Frenck Jr. R.W., Teleb N.A., Oun S.E., Sultan Y., Mansour H., and Mahoney F. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt. Vaccine 23 (2005) 3288-3293
28. De Wals P., Deceuninck G., Boulianne N., and De Serres G. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine. JAMA 292 (2004) 2491-2494
29. Goicoechea Saez M, Fullana Montoro AM, Momparler Carrasco P, Redondo Gallego MJ, Brines Solanes J, Bueno Canigral FJ. Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination (in Spanish). Rev Esp Salud Publica. 2003;77:125-142.
30. Pereiro I., Diez-Domingo J., Morant A., Gimeno C., Lerma M., San-Marti M., and Gonzalez A. Group for the Study of Invasive Diseases. Epidemiological pattern of meningococcal diseases in Valencia, Spain. Impact of mass immunization campaign with meningococcal C polysaccharide vaccine. Scand J Infect Dis 33 (2001) 581-584
31. Espin Rios I., Garcia-Fulgueiras A., Navarro Alonso J.A., Vazquez Moreno J., Rodriguez Gonzalez T., Navarro Sanchez C., et al. Seroconversion and duration of immunity after vaccination against group C meningococcal infection in young children. Vaccine 18 (2000) 2656-2660
32. De Wals P., Deceuninck G., De Serres G., Boivin J.F., Duval B., Remis R., et al. Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec. Clin Infect Dis 40 (2005) 1116-1122
33. Jensen E.S., Lundbye-Christensen S., Samuelsson S., Sørensen H.T., and Schønheyder H.C. A 20-year ecological study of the temporal association between influenza and meningococcal disease. Eur J Epidemiol 19 (2004) 181-187